CVE-2025-61940
02.12.2025, 21:15
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.Enginsight
Awaiting analysis
This vulnerability is currently awaiting analysis.
Common Weakness Enumeration